APEA Predictor Practice Exam 2026 – All-in-One Guide to Master Your Predictor Exam Success!

Administering bronchodilator therapy is the recommended first step in managing a patient with a confirmed asthma attack. During an asthma attack, the patient's airways become constricted due to inflammation and bronchospasm, leading to difficulty in breathing. Bronchodilators, specifically short-acting beta-agonists (SABAs), are designed to relax the muscles around the airways, thereby widening them and facilitating improved airflow. This rapid action helps to relieve acute symptoms such as wheezing, chest tightness, and shortness of breath effectively.

In this context, bronchodilators work swiftly to alleviate the immediate distress of an asthma attack, making them the priority treatment option before considering other supportive measures or therapies. Correctly addressing the acute bronchospasm allows for better oxygenation and serves as a crucial initial intervention.

Hydration and the encouragement of deep breathing exercises may be beneficial as part of a comprehensive asthma management plan, but they do not address the immediate physiological changes occurring during an asthma attack. Likewise, corticosteroid inhalers are typically used for long-term management and control of asthma rather than for the rapid relief needed during an acute episode. Thus, bronchodilator therapy is essential for quick relief and is the first line of action in such situations